Zenon Konteatis

2PUBLICATIONS
1CO-AUTHORS
Biomolecular modelling and designGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 08, 2021
Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous <i>MTAP</i> Deletion.

Zenon Konteatis, Jeremy Travins, Stefan Gross

Pageof 1

Frequent Collaborators